Skip to main content

Table 2 KEGG pathways of enriched genes

From: Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis

No KEGG ID KEGG term P-adjust Count
1 hsa04060 Cytokine–cytokine receptor interaction 8.57E−26 54
2 hsa04062 Chemokine signaling pathway 2.99E−17 36
3 hsa04514 Cell adhesion molecules (CAMs) 8.74E−12 26
4 hsa04640 Hematopoietic cell lineage 3.57E−15 25
5 hsa04380 Osteoclast differentiation 1.10E−10 23
6 hsa04650 Natural killer cell mediated cytotoxicity 4.65E−08 20
7 hsa05150 Staphylococcus aureus infection 3.54E−11 18
8 hsa04660 T cell receptor signaling pathway 1.04E−06 16
9 hsa05152 Tuberculosis 8.60E−04 16
10 hsa04064 NF-kappa B signaling pathway 5.23E−06 15
11 hsa04620 Toll-like receptor signaling pathway 8.06E−06 15
12 hsa05322 Systemic lupus erythematosus 1.18E−04 15
13 hsa05340 Primary immunodeficiency 4.36E−11 14
14 hsa05323 Rheumatoid arthritis 8.06E−06 14
15 hsa05142 Chagas disease 3.04E−05 14
16 hsa04659 Th17 cell differentiation 4.29E−05 14
17 hsa04145 Phagosome 1.56E−03 14
18 hsa04630 JAK-STAT signaling pathway 2.62E−03 14
19 hsa05332 Graft-versus-host disease 2.84E−09 13
20 hsa05162 Measles 1.95E−03 13
21 hsa05133 Pertussis 3.05E−05 12
22 hsa04611 Platelet activation 2.50E−03 12
23 hsa04610 Complement and coagulation cascades 2.22E−04 11
24 hsa04658 Th1 and Th2 cell differentiation 8.49E−04 11
24 hsa04672 Intestinal immune network for IgA production 2.12E−05 10
26 hsa05144 Malaria 2.12E−05 10
27 hsa04662 B cell receptor signaling pathway 1.95E−03 9
28 hsa05330 Allograft rejection 1.40E−04 8
29 hsa04940 Type I diabetes mellitus 3.30E−04 8
30 hsa05320 Autoimmune thyroid disease 1.36E−03 8
\